The Zhitong Finance App learned that Nurix Therapeutics (NRIX.US) continued its previous post-market decline before Wednesday after announcing that its partner SNY.US (SNY.US) decided to stop an experimental inflammatory disease treatment study. At press time, Nurix was down 32.96% to $17.31.

Zhitongcaijing · 21h ago
The Zhitong Finance App learned that Nurix Therapeutics (NRIX.US) continued its previous post-market decline before Wednesday after announcing that its partner SNY.US (SNY.US) decided to stop an experimental inflammatory disease treatment study. At press time, Nurix was down 32.96% to $17.31.